How patients deal with an ambiguous medical test: Decision-making after genetic testing.
Decision-making
Genetics
Hereditary breast cancer
Mental models
Patient-provider communication
Variant of uncertain significance
Journal
Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
31
03
2020
revised:
15
09
2020
accepted:
15
10
2020
pubmed:
21
11
2020
medline:
22
5
2021
entrez:
20
11
2020
Statut:
ppublish
Résumé
We know little about how patients make decisions when they receive a variant of uncertain significance result (VUS) from genetic testing. The purpose of this study was to elucidate a model of patient-informed decision-making after receiving a VUS result. Using an adapted Mental Models Approach, we conducted semi-structured interviews with women who received a VUS result from genetic testing for hereditary breast cancer (N = 20) to explore factors they believed were relevant to their decision-making. Two coders used a coding scheme informed by experts in hereditary breast cancer to conduct analysis. Inter-coder reliability was α = .86. Three overarching decision themes emerged from the interviews: managing ambiguity, medical risk management, and sharing results with others. While participants noted some difficulty understanding their result, genetic counselors' interpretations, psychosocial factors (e.g., risk perceptions), and competing extrinsic demands influenced their decisions. Complex influences affect patient decision-making after a VUS result from genetic testing and may encourage health protective behavior. Even patients who understand their test result could use support managing the ambiguity of their test result and sharing it with others.
Identifiants
pubmed: 33214013
pii: S0738-3991(20)30557-7
doi: 10.1016/j.pec.2020.10.020
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Pagination
953-959Subventions
Organisme : NCI NIH HHS
ID : R03 CA194643
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.